Travere Therapeutics TVTX
NASDAQ TVTX
$52.58 +0.28 (+0.54%)
At close: Oct 21, 2026 · 4:00 PM EDT

Travere Therapeutics (TVTX) Receivables - Other (2014 - 2018)

Updated

Travere Therapeutics' Receivables - Other was $562,500 in Q2 2018.

Analysis

Travere Therapeutics (TVTX) Receivables - Other (2014 - 2018) Analysis & Trends

  • The Q2 2018 figure marks the highest quarterly Receivables - Other since Q2 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Travere Therapeutics 4.93 Bn 4.53 Bn 167.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2018 562,500.00
Jun 30, 2014 5.96 Mn
API Access

Travere Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=TVTX&period=max&api_key=YOUR_API_KEY